{"schema_version":"secwatch.filing_event.v1","accession":"0001680367-23-000060","form_type":"8-K","ticker":"STTK","cik":"0001680367","company_name":"Shattuck Labs, Inc.","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.043651+00:00","generated_at":"2026-06-08T06:58:49.982091+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Shattuck reports Q3 net loss $27.5M; SL-172154 PROC ORR ~27% vs 4% benchmark","bullets":["Net loss of $27.5M ($0.65/share) for Q3 2023 vs $24.6M ($0.58/share) a year ago.","Cash and investments $101.1M as of Sep 30, 2023, sufficient to fund operations through 2024.","SL-172154 + PLD in PROC: 3 partial responses out of 11 evaluable patients (27% ORR), acceptable safety.","Topline data from Phase 1A/B in R/R AML/HR-MDS to be presented at ASH Dec 2023; abstract shows monotherapy response.","Expect to complete enrollment in PROC expansion and frontline HR-MDS cohorts in Q4 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001680367-23-000060","json":"https://secwatch.observer/filing/0001680367-23-000060.json","markdown":"https://secwatch.observer/filing/0001680367-23-000060.md","text":"https://secwatch.observer/filing/0001680367-23-000060.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680367/000168036723000060/0001680367-23-000060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680367/000168036723000060/sttk-20231109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T06:58:49.982091+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c0213121c14a3d4939f40d51fd7dcd1773045aed","claim":"Shattuck Labs, Inc. reported financial results for the quarter ended September 30, 2023.","evidence_excerpt":"On November 9, 2023, Shattuck Labs, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1680367/000168036723000060/0001680367-23-000060-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}